Please assess the completion status of the following clinical trial:

Trial Title: Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has a documented history of seasonal allergic rhinitis symptoms that flare up during the study season~* Patient is a nonsmoker and has been a nonsmoker for at least 1 year~* Patient is in good general health~Exclusion Criteria:~* Patient is hospitalized~* Patient is a woman who is less than 8 weeks postpartum or is breast-feeding~* Patient intends to move or vacation away during the study~* Patient has had any major surgery within 4 weeks of study start~* Patient is a current or past abuser of alcohol or illicit drugs~* Patient has been treated in an emergency room for asthma in the past month~* Patient had an upper respiratory infection with in 3 weeks prior to study start

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): montelukast
- 2 (Type: EXPERIMENTAL): loratadine
- 3 (Type: PLACEBO_COMPARATOR): placebo
- 4 (Type: EXPERIMENTAL): montelukast/loratadine

Based on this trial design, predict the completion outcome and termination type (if applicable).